Photo Credit: Kidney Cancer Canada/KCCure

Patient Voices

Research

Donate

Latest Post

Translocation Renal Cell Carcinoma (tRCC) Research Initiative

Translocation renal cell carcinoma (tRCC) is a rare subtype of renal cell carcinoma occurring in less than 5 percent of patients. Initially found primarily in c...Read More

Recent Posts

A Day of Kidney Cancer Talk – June 20th – World Kidney Cancer Day

KCCure and Kidney Cancer Canada join forces to bring patients and caregivers A DAY OF KIDNEY CANCER TALK on World Kidney Cancer Day! A DAY OF KIDNEY CANCER TALK...Read More

Voice of Kidney Cancer – Carol’s Story

In April 2019 the Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) in combination with Inlyta (axitinib) for the frontline treatment of pati...Read More

Tweets

Lost Password

Register

Subscribe for updates!